WHO Approves First-Ever Malaria Drug for Infants
GENEVA — In a landmark decision, the World Health Organization (WHO) has approved the first dedicated anti-malaria drug specifically designed for babies and young children — a breakthrough that could save hundreds of thousands of lives every year.Children under the age of five currently account for more than two-thirds of all global malaria-related deaths, making…
